SCHEMBL9316716

SCHEMBL9316716

CCOC(=O)CC(C[N+](=O)[O-])c1cc2cc(Br)ccc2o1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.43
KDM4E B2RXH2 2/20 0.39
LMNA P02545 2/20 0.39
USP2 O75604 2/20 0.39
HTT P42858 1/20 0.39
PIM1 P11309 1/20 0.39
MAOA P21397 2/20 0.38
CA12 O43570 2/20 0.37
CA9 Q16790 2/20 0.37
THRB P10828 2/20 0.37
GRIN1 Q05586 1/20 0.36
GRIN2A Q12879 1/20 0.36
GRIN2B Q13224 1/20 0.36
GRIN2C Q14957 1/20 0.36
GPR35 Q9HC97 1/20 0.36
TP53 P04637 1/20 0.36
MAPT P10636 1/20 0.35
POLB P06746 1/20 0.35
GPR55 Q9Y2T6 1/20 0.35
MAOB P27338 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9315765 0.90 TAS1R3 (0.41) ALDH1A1KDM4ELMNAMAOACA12
SCHEMBL9315934 0.88 KDM4E (0.39) ALDH1A1KDM4ELMNAMAOACA12
SCHEMBL9315814 0.88 TP53 (0.48) ALDH1A1KDM4ELMNAHTTTHRB
SCHEMBL9315905 0.88 CA12 (0.42) ALDH1A1KDM4ELMNAMAOACA12
SCHEMBL9315029 0.87 KDM4E (0.40) ALDH1A1KDM4ELMNAHTTMAOA
SCHEMBL9315780 0.85 LMNA (0.39) ALDH1A1KDM4ELMNAMAOATHRB
SCHEMBL9316711 0.80 MAPT (0.34) ALDH1A1KDM4ELMNAHTTPIM1
SCHEMBL482069 0.78 MAPT (0.46) ALDH1A1KDM4ELMNAHTTMAPT
SCHEMBL21609309 0.77 F10 (0.43) ALDH1A1KDM4ELMNAHTTMAPT
SCHEMBL30947795 0.77 F10 (0.43) ALDH1A1KDM4ELMNAHTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5278166-A 4-amino-3-heteroaryl butyric acid compounds, compositions, and their use for treating disorders involving a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1994-01-11 US disclosed
US-5214063-A 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors ADIR ET COMPAGNIE (FR) 1993-05-25 US disclosed
US-5162364-A Treatment of spastic and senescence disorders ADIR ET COMPAGNIE (FR) 1992-11-10 US disclosed